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Three-Dimensional Paper-Based Microfluidic Device for Assays of Protein
and Glucose in Urine
Abstract
The first step in curing a disease is being able to detect the disease effectively. Paper-based microfluidic devices
are biodegradable and can make diagnosing diseases cost-effective and easy in almost all environments. We
created a three-dimesnional (3D) paper device using wax printing fabrication technique and basic principles
of origami. This design allows for a versatile fabrication technique over previously reported patterning of SU-8
photoresist on chromatography paper by employing a readily available wax printer. The design also utilizes
multiple colorimetric assays that can accommodate one or more analytes including urine, blood, and saliva. In
this case to demonstrate the functionality of the 3D paper-based microfluidic system, a urinalysis of protein
and glucose assays is conducted. The amounts of glucose and protein introduced to the device are found to be
proportional to the color change of each assay. This color change was quantified by use of Adobe Photoshop.
Urine samples from participants with no pre-existing health conditions and one person with diabetes were
collected and compared against synthetic urine samples with predetermined glucose and protein levels.
Utilizing this method, we were able to confirm that both protein and glucose levels were in fact within healthy
ranges for healthy participants. For the participant with diabetes, glucose was found to be above the healthy
range while the protein level was in the healthy range.
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Three-Dimensional Paper-Based Microﬂuidic Device for Assays of
Protein and Glucose in Urine
Deidre Sechi, Brady Greer, Jesse Johnson, and Nastaran Hashemi*
Department of Mechanical Engineering, Iowa State University, Ames, Iowa, United States
ABSTRACT: The ﬁrst step in curing a disease is being able to
detect the disease eﬀectively. Paper-based microﬂuidic devices
are biodegradable and can make diagnosing diseases cost-
eﬀective and easy in almost all environments. We created a
three-dimesnional (3D) paper device using wax printing
fabrication technique and basic principles of origami. This
design allows for a versatile fabrication technique over
previously reported patterning of SU-8 photoresist on
chromatography paper by employing a readily available wax
printer. The design also utilizes multiple colorimetric assays
that can accommodate one or more analytes including urine,
blood, and saliva. In this case to demonstrate the functionality
of the 3D paper-based microﬂuidic system, a urinalysis of
protein and glucose assays is conducted. The amounts of glucose and protein introduced to the device are found to be
proportional to the color change of each assay. This color change was quantiﬁed by use of Adobe Photoshop. Urine samples from
participants with no pre-existing health conditions and one person with diabetes were collected and compared against synthetic
urine samples with predetermined glucose and protein levels. Utilizing this method, we were able to conﬁrm that both protein
and glucose levels were in fact within healthy ranges for healthy participants. For the participant with diabetes, glucose was found
to be above the healthy range while the protein level was in the healthy range.
Diseases surround the world and being able to diagnosethem is crucial in order to then cure the disease.
Diagnosing diseases is not always an aﬀordable, time-eﬃcient,
or easy task. Paper-based microﬂuidic devices construct a
framework that leaves the level of complication and cost low
while keeping the eﬃciency high.1−6 The application of paper-
based microﬂuidics presents many advantages such as their cost
eﬀectiveness: they are easy to mass-produce, transport, store,
implement, dispose, and they do not need excessive equipment
to move liquid like other devices. There are also many
disadvantages to paper-based microﬂuidic devices. They are
relatively new, which means issues such as the control over ﬂow
rates, mixing, and interaction times between sample and
reagents have not yet been perfected.7−9
A previous approach by Liu and Crooks10 uses photo-
lithography and origami to develop a 3D paper-based analytical
device (μPAD). The inclusion of origami to the overall design
of the μPAD allows for only one step of the fabrication process.
The μPAD can be simply folded into multiple layers. This also
eliminates the contamination and nonspeciﬁc adsorption
caused by using tape in previous 3D designs.3 Following the
procedure, analysis can be done by unfolding the μPAD,
revealing the colorimetric and ﬂuorescence assays on each layer.
Photolithography patterns the paper by use of a light-sensitive
chemical as photoresist, creating a pattern on the paper to
control ﬂuid ﬂow without any input of excess energy such as a
pump or valve system in glass-based microﬂuidic systems to
direct or manipulate the ﬂuid. Still using only small samples
from the test subject, approximately 5 μL, allows for multiple
diagnostic tests on one μPAD, resulting in an inexpensive,
portable device.11
Like photolithography, wax printing is a simple and
inexpensive method of fabricating a μPAD, as discussed by
Whitesides and co-workers.3 Fabrication by wax printing
involves only two main procedures: the ﬁrst step is printing
patterns of wax on the surface of paper, and the second is
melting the wax into the paper to form hydrophobic barriers.
This can prevent any mixing of the ﬂuids passing through the
device. The low cost of production and low levels of complexity
to create these paper-based analytical devices make them well-
suited to be manufactured at a large scale for prototyping. The
features are not as accurate as other methods such as
photolithography but are suﬃcient for uses such as detecting
substances due to color change in the test assay. The melting of
the wax is both lateral and vertical, spreading across the paper
and creating a hydrophobic barrier across the thickness of the
paper.
Most published work focuses on ready-to-use microﬂuidic
devices. For instance, paper-based blood typing devices can be
used to detect the presence or absence of hemagglutination
reactions, which can lead to rapid identiﬁcation of human blood
type at a signiﬁcantly lower cost than current mainstream
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methods. These tests can be operated without the assistance of
medical personnel, making these devices attractive for
diagnostic applications in remote locations and the developing
world.12 Other applications for these devices include
simultaneous detection of analytes within a test sample and
microﬂuidic origami chemiluminescence detection system for
point-of-care (POC) diagnostics.13 There are multiple
techniques to create these devices including photolithography
plotting,11,14,15 plasma oxidation,14 ﬂexography printing,14 wax
printing,16 and inkjet printing.4,15 Along with the number of
techniques utilized, there is a wide variety of hydrophobic
substances available for creating channels on hydrophilic paper,
each with its own advantages and disadvantages.
Wax printing and ink jet printing are proving to be the most
promising of fabrication methods due to their low-cost
patterning and quick fabrication process. Wax printing is also
an ideal form of production for mass prototyping, which is
essential for low-cost portable diagnostic devices that could be
used in remote locations in developing regions. Ideally, we are
interested in diagnostic devices that do not require extra
equipment or power to operate. Overall, the advantages of
paper-based diagnostic devices may become a driving force for
rapid, cheap, ﬂexible, and reliable devices to be developed for
clinical emergency as well as large-scale use in developing
regions where reliability, aﬀordability, and user friendliness are
major challenges.
This paper focuses on the use of wax printing and basic
origami folding technique to fabricate 3D μPADs and its
advantages over previous fabrication methods because of its low
-cost, simplicity, and capability to produce large amounts of
prototypes rapidly. The nine-layer platform along with the basic
yet versatile reservoir and channel design allows for several
analyte to assay combinations that can be easily tailored to a
speciﬁc region of the world, or a certain physician’s expertise,
where a certain set of diagnoses are speciﬁcally sought after.
These changes can be made with minimal eﬀort and eﬀect on
the reproducibility of the device’s performance.10 The design
can be set to simultaneously test urine, blood, and saliva
samples in their respective assays, or a single analyte can be
tested to its full extent. For example, urine can be colorimetri-
cally tested for glucose, protein, nitrites, bilirubin, urobilinogen,
ketones, erythrocytes, and leukocytes.17
We speciﬁcally use the prototype developed by wax printing
to test protein and glucose levels within a human urine sample.
The design of the prototype μPAD requires very small sample
sizes; in the case of a urine sample, 3 μL is all that is necessary.
The μPAD proved to be cost-eﬀective in its fabrication, to
maintain reliability when mass-produced, to have a simple
procedure for its administration, and to have the ability to give
several diagnoses per limited amount of test sample. This
device could also be integrated with technologies such as
lensless imaging18,19 for POC diagnostics in resource-limited
regions. For users who do not have access to scanners and
programs to manipulate the results, the device still can be used
to qualitatively evaluate the color change. For instance, a simple
colorimetric guide can accompany the device depicting
sequences of sequential color change respectively matched
alongside the corresponding compound concentration range
which gives each description, quantitatively predetermined in
the lab. This way, the user can simply match color schemes
from the guide to the test sample.
■ MATERIALS AND METHODS
In order to make this device cost-eﬃcient while still being
portable, minimal materials are necessary. The ﬁrst step to
create the microﬂuidic device is to choose the paper on which
they are printed. The paper needs to allow the mixtures to ﬂow
but also have barriers that can control the ﬂow. As discussed by
Whitesides and co-workers,20 wax printing is very aﬀordable
and easy to use by utilizing a standard printer (Xerox
ColorQube 8570DN) that prints wax instead of ink. Previous
studies chose Whatman no. 1 chromotography paper (costing
about $7/m2 and available in sheets of 460 mm × 570 mm) due
Figure 1. (a) Unfolded paper-based microﬂuidic device made by wax printing technique. Detection reservoirs are shown by yellow rectangles for
protein and orange rectangles for glucose. The image shows the ﬂow of colored solutions from the entrance points to the bottom layers. (b) Flow
pattern of the microﬂuidic device. Sample is introduced in the top left corner and ends in the bottom middle square.
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to its hydrophilic and biocompatible behavior as well as low
cost.
The design was ﬁrst created in SolidWorks 2011 and then
printed onto the paper. Once the wax was printed onto the
paper, it was put into an oven at 150 °C for 120 s. This heating
process allows the wax to melt into the Whatman no. 1
chromotography paper both vertically and horizontally, creating
a hydrophobic blockade throughout the paper forming a
barrier. This works for both the lateral ﬂow devices and 3D
models. After the paper was chosen, the thickness of the ink
line was tested for the required width of line to create a fully
hydrophobic barrier. This was tested by drawing ﬁve rectangles
and performing the fabrication process with diﬀerent beginning
line widths. Colored water was placed in the center of the
rectangles after the wax was melted. It was found that the
smallest original line width, while still maintaining a hydro-
phobic barrier, was 400 μm, and after melting it was expanded
to 1000 μm. The simplicity of the device allows the overall cost
to be minimal.
The next step was preparing the assays for the detection
points. Two assay kits were purchased from Sigma−Aldrich.
The assays purchased were (TP0100) for protein and (GAGO-
20) for glucose. With the glucose assay being used as is, the
protein assay needed to be prepared by dilution. The ratio used
was 4:1 distilled water to protein.
By use of the 3D origami technique, a prototype can be
created by folding the device into a three-dimensional shape.
Because of the hydrophobic channels created from the wax
printing technique, the sample ﬂows through the channels
toward the detection points. The 3D model is important
because it ﬂows in the x, y, and z directions, allowing multiple
detection points on a small footprint. The glucose and protein
assays were placed on diﬀerent layers of the device (outlined
with rectangles as shown in Figure 1a), prior to the experiment
and were allowed to dry at 20 °C for 30 min. Once the assays
were dry, the device was placed in four plastic corner sleeves to
ensure tight contact between layers, and a sample (3 μL) of
urine was introduced at the entrance point to the nine-layer
device, with ﬂuid ﬂow directed in the three dimensions. To
gauge the eﬀect of protein and glucose levels on the color
change in the assays, synthetic urine with predetermined levels
was analyzed along with actual urine samples from four
volunteers. Synthetic urine samples with protein and glucose
were prepared separately and tested simultaneously on one
μPAD.
Subsequently, individual human urine samples were simulta-
neously tested for protein and glucose levels on the same
μPAD. The samples were allowed to completely react until dry
with the glucose and protein assay to ensure the best before-
and-after evaluation of color change. Once the reaction was
complete, the device was unfolded to observe the testing assays
for colorimetric analysis. Scans were taken immediately after
drying due to the color fading in the detection points after 20
min. The color in the detection points after reaction occurred
was captured by use of a HP Scanjet 6300c with a resolution of
600 dpi. Multiple devices can be scanned at once into the same
ﬁle. Once scanned, the pictures were uploaded into Photoshop
to measure the color change that occurred from mixing. When
mixed with urine, the glucose assay changes from clear to
brown, while the protein assay changes from brown to a lighter
shade of brown. The changing color of glucose is considered
the same color with only the shade changing; this was analyzed
with grayscale. Color was discarded in Photoshop by selecting
grayscale. The histogram tool was used to show the brightness
or darkness level of a certain area. The part of the picture that
was being analyzed was then selected, including only the
colored parts of the detection zone and omitting the ink
outline. By clicking in the middle of the selected box and
dragging it, the same amount of pixels can be used for every
branch. The mean average brightness with the amount of pixels
will then be shown on the histogram box. From this, the color
change was quantiﬁed for the results. For glucose, the grayscale
shade change was recorded, and for protein, the RGB (red,
green, blue) averages were recorded.
■ RESULTS AND DISCUSSION
In order to test the device, ﬁrst we studied the correlation of
color change and the known amount of protein and glucose in
synthetic urine. A graph was created by plotting the exact color
change in pixels versus the amount of glucose and protein in
the synthetic urine sample (Figures 2 and 3). A best-ﬁt line was
Figure 2. Color change as a function of known amounts of glucose
(blue diamonds). This creates a scale that can be referenced when
experiments are conducted. Based on the color change measured in
Photoshop, participant 1 (green square) displayed a color change of
0.5 pixel, equivalent to 0.3 mg/dL glucose. Participant 2 (red triangle)
displayed a color change of 0.35 pixel, indicating a value of 0.05 mg/dL
glucose. Participant 3 (orange asterisk), displayed a color change of
0.81 pixel or 0.8 mg/dL glucose. Participant 4 (not shown) displayed a
color change of 71 pixels or 114.8 mg/dL glucose. Normal glucose
range in urine must be below 15 mg/dL.
Figure 3. Relationship between color change and amount of protein in
urine samples (blue diamonds). Protein levels of participants 1−4 are
shown as green square, red triangle, orange asterisk, and black plus
sign, respectivelyf. The average color change ranges from 18.5 to 17
pixels, indicating protein levels that range from 6.3 to 10.4 mg/dL.
Normal protein range in urine is less than 10 mg/dL.
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applied to the data, giving an equation for the line. This can be
used later to determine the amount of protein or glucose each
participant had in their urine sample. A wide spectrum of
results was obtained by testing diﬀerent amounts of glucose and
protein in synthetic urine and the eﬀect each one had on color
change. For glucose the amounts chosen were 0.25, 1, 2, 4, 6,
and 8 mg/dL. The healthy range for glucose is less than 15 mg/
dL, so the amounts we chose were to establish the trend within
that range.
For protein, standard amounts of 5, 10, 15, and 20 mg/dL
were used. The healthy range for protein levels is less than 10
mg/dL. There are a number of factors that could lead to higher
levels of protein, as opposed to glucose, where the main factor
would be diabetes. For this reason we chose protein levels in
the synthetic samples outside the health zone to accommodate
for the seemingly healthy individual. Each experiment was
performed ﬁve times to ﬁnd an average and standard deviation
for sets of data.
Once the correlation between color change and the amount
of protein or glucose was found, actual urine samples from four
volunteers were analyzed. Of these volunteers, two were male
and two were female, ages 21−48 with a weight range of 120−
215 lbs. The samples were taken before breakfast. Three of the
participants had no pre-existing health conditions documented.
Each participant’s sample was tested by the three-dimensional
device by the same method as the synthetic urine. A
commercial blood glucose meter, ACCU-CHEK Compact
Plus, was employed as another validation technique. The
samples were also sent to a laboratory for urinalysis testing.
Reagent strips were used for testing. Each strip tests for two
markers, glucose and protein. The amount of glucose and
protein in the urine and blood samples of each volunteer was
measured by all three techniques.
The results show that the participants with no pre-existing
health conditions were in the healthy ranges of protein and
glucose levels. The glucose level in urine for the participant
with diabetes (control) was found to be 114.8 mg/dL, which is
not shown in Figure 2. The protein level for this person was
found to be 9.2 mg/dL and is shown as a black plus sign in
Figure 3.
The danger zone or unhealthy zone for protein is more than
10 mg/dL protein in the urine. The presence of a larger
amount of protein in urine may be related to kidney diseases
such as glomerulonephritis. It may also be due to illnesses such
as heart failure, high blood pressure, or bladder tumor. Having
glucose in the urine can be a sign of diabetes. The appropriate
level of glucose that is allowed in urine sample is in the range
0−15 mg/dL.
Table 1 summarizes the amounts of protein and glucose
measured by our 3D device, laboratory urinalysis testing, and a
commercial glucose meter. In laboratory tests, “neg” represents
normal urine containing little or no protein or glucose and
“trace” represents a glucose level of 100 mg/dL in urine sample.
Both laboratory tests and our 3D device showed that the
glucose levels were pretty small for participants 1−3 and about
100 mg/dL for participant 4. Fasting blood sugar above 130
mg/dL is reported as diabetes by the American Diabetes
Association (ADA). The glucose levels in urine samples were
very low compared to the blood samples. However, the results
follow the same trend. Participants 1−3 were found to have
glucose amounts below 1 mg/dL in their urine samples and
their blood glucose levels were also in the healthy range. The
glucose level for participant 4 was above the indicated healthy
range in both blood and urine samples. The protein level for all
participants was in the healthy range as measured by both our
3D paper device and laboratory urinalysis testing.
From the results in this experiment, it can be seen that a
logical estimation can be made of protein and glucose levels
with a simple diagnostic test using a paper microﬂuidic device.
By experimenting with known amounts of glucose and protein
initially, a relationship was determined between the average
color change and the actual quantities in the sample. A quick
and easy test of a urine sample and referencing the relationship
on the graph will give an estimation of protein and glucose
amounts. Although only a few layers were needed for this
simple test of urine samples, it is apparent that more complex
studies and tests can be performed by using the inexpensive
fabrication method of wax printing and applying the origami
technique. To be able to analyze more substances within the
ﬂuid, more layers within the device would be needed. Since all
layers are fabricated at the same time, the construction of more
will not pose much of an obstacle.
■ CONCLUSIONS
It is shown that paper-based microﬂuidic devices have lots of
potential. They are ﬂexible, lightweight, biodegradable, and can
be extraordinarily cheap. Paper can reach what seems like an
endless range of properties whether it is hydrophobic,
hydrophilic, porous, watertight, , or transparent. In terms of
microﬂuidics, the versatility of paper leaves a lot of room for
creativity in the design of 3D assays. This paper focused on
creating a paper-based microﬂuidic device that has a high
degree of utility, is user-friendly, eﬃcient to produce, and even
easy to customize. With the use of origami and wax printing, a
microﬂuidic device was created that required very little test
sample, simple administration, and little time to use. To
demonstrate the eﬀectiveness of the device, assays were
prepared to test human urine samples and to give an estimation
of glucose and protein amounts in the samples. Synthetic urine
samples with predetermined levels of protein and glucose were
Table 1. Protein and Glucose Levels Measured by 3D Paper Device, Laboratory Urinalysis Testing, and Commercial Glucose
Meter
glucose protein
participant
color change
(pixels)
in urine (mg/
dL)
lab urinalysis
testinga
in bloodb (mg/
dL)
color change
(pixels)
in urine (mg/
dL)
lab urinalysis
testinga
1 0.5 0.3 neg 74 18.5 6.3 neg
2 0.35 0.05 neg 72 17 10.4 neg
3 0.81 0.8 neg 82 18.2 7.2 neg
4 71 114.8 trace 143 17.5 9.2 neg
aNegative (neg) represents normal urine containing little or no protein or glucose. Trace represents glucose level of 100 mg/dL in urine sample. bBy
ACCU-CHEK Compact Plus.
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also prepared to calibrate the eﬀects on the color change. Urine
samples from four participants with and without pre-existing
health conditions were collected and analyzed. The results
aﬃrmed that both protein and glucose amounts were in healthy
ranges for participants with no health conditions. The glucose
level for the participant with diabetes was found to be above the
healthy range while the protein level was in the healthy range.
Overall the eﬀectiveness, simplicity, and versatility of the
origami paper-based microﬂuidic device is shown to be a viable
tool with great potential in POC diagnostics.
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